A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : L-DOPA

Search Conditions:
Search Keyword : L-DOPA
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: L-DOPA
Appearance Frequency: 937 time(s)
Long forms: 29

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
L-3,4-dihydroxyphenylalanine
(904 times)
Neurology
(272 times)
DA (168 times)
PD (150 times)
TH (55 times)
1962 [The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis].
L-tyrosine and 3,4-dihydroxy-L-phenylalanine
(5 times)
Biochemistry
(2 times)
AADCs (1 time)
alpha-KG (1 time)
PP (1 time)
1984 Differences in properties between aromatic amino acid: aromatic keto acid aminotransferases and aromatic amino acid: alpha-ketoglutarate aminotransferases.
L-3,4-dihydroxyphenylacetic acid
(2 times)
Neurology
(2 times)
5-HIAA (1 time)
DA (1 time)
GCs (1 time)
1986 Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
11C-labeled 3,4-Dihydroxy-phenyl-L-alanine
(1 time)
Brain
(1 time)
--- 1999 A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
D1-like receptors in the development of dopamine precursor molecule 3,4-dihydroxyphenyl-L-alanine
(1 time)
Psychiatry
(1 time)
--- 2009 Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
DOPA control
(1 time)
Neurology
(1 time)
5-HTP (1 time)
1992 Suppression of annual testicular development in Indian Palm squirrel, Funambulus pennanti by 8 hr temporal relationship of serotonin and dopamine precursor drugs.
L-3, (Del-Bel et al., Cell Mol Neurobiol 25(2):371-392, 2005) 4-dihydroxyphenylalanine
(1 time)
Neurology
(1 time)
DOPAC (1 time)
i.p (1 time)
2014 Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment.
L-3,4-dihydroxyphenylalanine methyl ester
(1 time)
Neurology
(1 time)
LRRK2 (1 time)
MPTP (1 time)
2007 Striatal leucine-rich repeat kinase 2 mRNA is increased in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned common marmosets (Callithrix jacchus) with L-3, 4-dihydroxyphenylalanine methyl ester-induced dyskinesia.
L-3,4-DihydrOxyPhenylAlanine or levodopa
(1 time)
Neuropharmacology
(1 time)
CNS (1 time)
GPCRs (1 time)
PD (1 time)
2018 In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.
10  L-beta-3,4-Dihydroxyphenylalanine hydrochloride
(1 time)
Biochemistry
(1 time)
L-Dopa (1 time)
1997 Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors.
11  L-Dihydroxyphenylalanine, dopamine precursor
(1 time)
Neurology
(1 time)
5-HTP (1 time)
1992 Suppression of annual testicular development in Indian Palm squirrel, Funambulus pennanti by 8 hr temporal relationship of serotonin and dopamine precursor drugs.
12  L-dopamine
(1 time)
Biochemistry
(1 time)
PD (1 time)
2018 Peripheral T lymphocyte immunity and l-dopamine in patients with Parkinson's disease.
13  L-tyrosine is gaining grounds as the market size of 3,4-dihydroxyphenyl-L-alanine
(1 time)
Biotechnology
(1 time)
--- 2019 Metabolic engineering of Escherichia coli BL21 (DE3) for de novo production of L-DOPA from D-glucose.
14  L-tyrosine to (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
(1 time)
Chemistry
(1 time)
HRP (1 time)
NTA-OMPSs (1 time)
UPPs (1 time)
2011 Specifically and reversibly immobilizing proteins/enzymes to nitriolotriacetic-acid-modified mesoporous silicas through histidine tags for purification or catalysis.
15  laboratory auto-oxidation of 3,4-dihydroxy-L-phenylalanine
(1 time)
Fluorescence
(1 time)
DHICA (1 time)
2014 Metal ion influence on eumelanin fluorescence and structure.
16  latency, but a DA precursor, 3,4-dihydroxyphenylalanine
(1 time)
Pharmacology
(1 time)
5-HTP (1 time)
DA (1 time)
NE (1 time)
1989 Some correlations between procaine-induced convulsions and monoamines in the spinal cord of rats.
17  lesions decreased contralateral stepping by 74-83%, and 8 mg/kg 3,4-dihydroxy-L-phenylalanine
(1 time)
Psychopharmacology
(1 time)
MFB (1 time)
PD (1 time)
2009 The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat.
18  lesions of the nigrostriatal dopaminergic pathway, I-dihydroxyphenylalanine
(1 time)
Drug Therapy
(1 time)
CPu (1 time)
NMDA (1 time)
1992 Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
19  levels and 3,4-dihydroxy-L-phenylalanine
(1 time)
Chemistry
(1 time)
DA (1 time)
DOPAC (1 time)
2015 D1 Antagonists and D2 Agonists Have Opposite Effects on the Metabolism of Dopamine in the Rat Striatum.
20  Levodapa
(1 time)
Neurology
(1 time)
FDM (1 time)
SM (1 time)
2017 Different roles of retinal dopamine in albino Guinea pig myopia.
21  levodopa-treatment
(1 time)
Brain
(1 time)
6-OHDA (1 time)
L-AP4 (1 time)
mGlu (1 time)
2002 Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment.
22  light microscopic immunocytochemical study, with antisera against dihydroxyphenylalanine
(1 time)
Neurology
(1 time)
DA (1 time)
ir (1 time)
TH (1 time)
1994 Immunocytochemical localization of L-dopa and dopamine in the brain of the chicken (Gallus domesticus).
23  loading with 3,4-dihydroxyphenyl-L-alanine
(1 time)
Neurology
(1 time)
5-HIAA (1 time)
5-HT (1 time)
MAO (1 time)
2004 Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats.
24  locomotor responses of these DA-deficient (DA-/-) mice to 3, 4-dihyroxy-L-phenylalanine
(1 time)
Science
(1 time)
DA (1 time)
WT (1 time)
1999 Feeding behavior in dopamine-deficient mice.
25  loss of lateralization in levodopa
(1 time)
Molecular Biology
(1 time)
--- 2016 Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum.
26  loss of midbrain dopaminergic neurons and 3,4-dihydroxyphenylalanine
(1 time)
Neurology
(1 time)
ak (1 time)
PD (1 time)
2005 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease.
27  low-dose levodopa
(1 time)
Medicine
(1 time)
ROS (1 time)
2014 Low-dose levodopa protects nerve cells from oxidative stress and up-regulates expression of pCREB and CD39.
28  ortho-hydroxylated derivative of the dopamine precursor 2,4-dihydroxyphenylalanine
(1 time)
Neurology
(1 time)
EAA (1 time)
non-NMDA (1 time)
1991 2,4,5-Trihydroxyphenylalanine (6-hydroxy-dopa) displaces [3H]AMPA binding in rat striatum.
29  PD-like symptoms, treated 8 of these animals with 3,4-dihydroxy-l-phenylalanine
(1 time)
Neurosurgery
(1 time)
AMPA (1 time)
GP (1 time)
LIDs (1 time)
2015 Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.